|4Feb 6, 8:00 PM ET

ENDOCYTE INC 4

4 · ENDOCYTE INC · Filed Feb 6, 2015

Insider Transaction Report

Form 4
Period: 2015-02-04
Ellis P Ron
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2015-02-04+26,875252,840 total
  • Award

    Stock Option (right to buy)

    2015-02-04+161,250161,250 total
    Exercise: $5.10Exp: 2025-02-04Common Stock (161,250 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units that will vest and be paid 1/3 annually over a period of 3 years beginning on February 4, 2016, in the form of one share of common stock for each restricted stock unit.
  • [F2]Shares subject to the option vest 1/3 annually over a period of 3 years beginning on February 4, 2016.

Documents

1 file
  • 4
    v400756_4.xmlPrimary

    OWNERSHIP DOCUMENT